Press release
Pars Planitis Market Forecast to Grow at 6.5% CAGR, Reaching USD 780 Million by 2034
Pars Planitis Market
Pars planitis is a rare, idiopathic inflammatory condition of the eye that primarily affects the pars plana region of the ciliary body. Classified as a subset of intermediate uveitis, it typically impacts children and young adults and is characterized by floaters, blurred vision, and vitreous opacities. Although not life-threatening, untreated pars planitis can lead to complications such as macular edema, cataracts, or retinal detachment, significantly affecting quality of life.
Over the past decade, advances in immunomodulatory therapies, biologics, and improved diagnostic tools have enhanced disease management. With increasing awareness of autoimmune disorders, growing investments in rare disease research, and advancements in ocular imaging, the pars planitis market is expected to experience steady growth. By 2034, the market will reflect strong adoption of biologics, corticosteroid-sparing agents, and precision medicine approaches.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72272
Market Overview
• Market Size (2024): USD 410 million
• Forecast (2034): USD 780 million
• CAGR (2024-2034): ~6.5%
Key Highlights:
• Rising prevalence of uveitis and autoimmune-related ocular conditions.
• Growing role of corticosteroid-sparing biologics in disease management.
• Increased utilization of advanced imaging techniques such as OCT (optical coherence tomography) and fluorescein angiography for accurate diagnosis.
• Expanding patient awareness and rare disease funding fueling research and treatment accessibility.
Leading Players: AbbVie (Allergan), Novartis, Roche/Genentech, Bausch + Lomb, Santen Pharmaceutical, Regeneron Pharmaceuticals, and smaller biotech companies developing novel immunotherapies.
Key Drivers: Advances in biologics, rare disease programs, and increased ophthalmic diagnostic adoption.
Key Challenges: High cost of biologic therapies, underdiagnosis in developing countries, and limited clinical trial participation due to disease rarity.
Segmentation Analysis
By Product
• Corticosteroids (topical, periocular, systemic)
• Immunosuppressive Agents (methotrexate, cyclosporine, azathioprine)
• Biologic Therapies (anti-TNF agents, anti-IL therapies)
• Diagnostic Imaging Tools (OCT, fundus photography, angiography)
• Others (emerging gene or cell-based therapies)
By Platform
• Prescription Drugs
• Biologics & Specialty Drugs
• Diagnostic Platforms
By Technology
• Immunomodulation & Targeted Biologics
• Corticosteroid Delivery (implants, sustained release)
• Advanced Imaging (OCT, fundus cameras, AI-driven diagnostics)
• Regenerative & Experimental Therapies
By End Use
• Hospitals
• Ophthalmology Clinics
• Specialty Eye Care Centers
• Research Institutes
By Application
• Pediatric Patients
• Young Adults
• Adults with Secondary Autoimmune Associations
• Clinical Trials & Experimental Treatments
Summary: While corticosteroids remain first-line therapy, the market is rapidly shifting toward biologics and immunomodulatory agents that minimize long-term steroid complications. Diagnostic imaging technologies also hold strong growth potential, particularly in early disease detection and management.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72272/pars-planitis-market
Regional Analysis
North America
• Largest market due to advanced healthcare systems and access to biologics.
• Strong presence of leading pharmaceutical players and clinical research programs.
• Favorable reimbursement policies supporting rare disease therapies.
Europe
• Robust growth supported by EU rare disease initiatives and research funding.
• Germany, UK, and France lead in adoption of biologics and corticosteroid-sparing agents.
• Expanding access to advanced ophthalmic imaging devices.
Asia-Pacific
• Fastest-growing region, with China, Japan, and India leading adoption.
• Increasing awareness of uveitis-related conditions.
• Expanding healthcare infrastructure and growing participation in clinical trials.
Middle East & Africa
• Rising recognition of autoimmune eye disorders in GCC countries.
• Limited access to advanced biologics in low-income nations, though generic immunosuppressants are available.
• Government healthcare reforms supporting ophthalmic care investments.
Latin America
• Brazil and Mexico drive regional growth.
• Expanding ophthalmology networks and patient support programs.
• Rising demand for cost-effective biologics and generic immunosuppressants.
Summary: North America and Europe dominate the current market due to advanced healthcare access and strong innovation pipelines, while Asia-Pacific is the fastest-growing market, benefiting from larger patient pools, expanding infrastructure, and growing awareness initiatives.
Market Dynamics
Growth Drivers
1. Advances in Biologics: Targeted therapies reducing long-term corticosteroid dependence.
2. Rare Disease Funding: Growing orphan drug incentives encouraging R&D in pars planitis.
3. Diagnostic Innovation: Wider adoption of OCT and AI-assisted imaging tools.
4. Patient Awareness: Expanding education initiatives promoting early diagnosis.
Challenges
1. High Treatment Costs: Biologics and sustained-release implants remain expensive.
2. Underdiagnosis: Limited recognition of pars planitis in low- and middle-income countries.
3. Small Patient Population: Rare disease nature limits large-scale clinical trials.
4. Treatment Side Effects: Corticosteroid-related complications drive need for safer alternatives.
Latest Trends
• AI in Imaging: Automated OCT and fundus analysis for early and accurate diagnosis.
• Sustained-Release Corticosteroid Implants: Improving patient compliance and reducing injection frequency.
• Biologic Pipeline Expansion: Anti-TNF and anti-IL therapies advancing through clinical trials.
• Regenerative & Gene Therapy Research: Potential long-term solutions under early investigation.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72272
Competitor Analysis
Major Players:
• AbbVie (Allergan)
• Novartis AG
• Roche/Genentech
• Bausch + Lomb
• Regeneron Pharmaceuticals
• Santen Pharmaceutical
• Alimera Sciences (ocular implants)
• Clearside Biomedical (suprachoroidal delivery systems)
• Biogen Inc. (autoimmune drug development)
• Emerging biotech firms in gene and regenerative medicine
Competitive Dynamics:
The pars planitis market is characterized by pharma giants dominating biologics while innovative biotech startups lead in imaging and regenerative research. Collaborations, licensing agreements, and R&D partnerships are common, particularly in biologic therapy development. Companies are also investing in sustained-release corticosteroid implants and AI-based diagnostic platforms to enhance long-term disease management.
Conclusion
The pars planitis market is projected to grow from USD 410 million in 2024 to USD 780 million by 2034, at a CAGR of ~6.5%. Growth will be driven by biologic therapies, advanced diagnostic technologies, and rare disease initiatives.
Despite challenges such as high treatment costs and underdiagnosis, the long-term outlook is optimistic. Expanding access to biologics, rising clinical trial activity, and the integration of AI in ophthalmology are set to redefine patient care.
This report is also available in the following languages : Japanese (部分扁平化部市場), Korean (파스 플라니티스 시장), Chinese (帕尔斯普拉尼蒂斯市场), French (Marché de Pars Planitis), German (Pars Planitis Markt), and Italian (Mercato di Pars Planitis), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72272
Our More Reports:
Acute Ocular Pain Market
https://exactitudeconsultancy.com/reports/72218/acute-ocular-pain-market
Transcatheter Embolization And Occlusion Devices Market
https://exactitudeconsultancy.com/reports/72134/transcatheter-embolization-and-occlusion-devices-market
Neurological Diagnostic and Monitoring Equipment Market
https://exactitudeconsultancy.com/reports/72132/neurological-diagnostic-and-monitoring-equipment-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pars Planitis Market Forecast to Grow at 6.5% CAGR, Reaching USD 780 Million by 2034 here
News-ID: 4193903 • Views: …
More Releases from Exactitude Consultancy
Retinal Neovascularization Market Expected to Grow at 6.6% CAGR, Reaching USD 19 …
Introduction
Retinal neovascularization is a pathological process characterized by the abnormal growth of new blood vessels in the retina, often associated with diseases such as diabetic retinopathy, retinal vein occlusion, and age-related macular degeneration. These fragile vessels can leak blood or fluid, leading to macular edema, scarring, and potentially permanent vision loss. As diabetes prevalence rises globally and populations age, retinal neovascularization has become a growing concern in ophthalmology and public…
Ptosis Market Projected to Grow at 6.7% CAGR, Reaching USD 2.3 Billion by 2034
Introduction
Ptosis, commonly referred to as "drooping eyelids," can be congenital or acquired and affects both functional vision and facial appearance. While mild cases may primarily be cosmetic, severe ptosis can obstruct vision, interfere with daily activities, and affect quality of life. The condition has gained increasing medical and aesthetic attention due to its dual impact on eye health and appearance.
Management options for ptosis range from surgical correction (levator resection, frontalis…
Optic Neuropathy Market Expected to Grow at 6.9% CAGR, Reaching USD 2.7 Billion …
Introduction
Optic neuropathy, a group of disorders caused by damage to the optic nerve, is a significant contributor to vision impairment and blindness worldwide. It can arise from a wide range of causes, including ischemia, inflammation, trauma, toxins, glaucoma, hereditary conditions, and neurodegenerative diseases. Unlike refractive errors or cataracts, optic neuropathy often leads to irreversible damage, making early diagnosis and neuroprotective interventions critical.
The optic neuropathy market is expanding as healthcare systems…
Optic Atrophy Market Projected to Grow at 6.8% CAGR, Reaching USD 1.2 Billion by …
Introduction
Optic atrophy, a condition characterized by the degeneration of optic nerve fibers leading to progressive vision loss, remains a serious global health challenge. Unlike other eye diseases, optic atrophy is not a single disorder but a manifestation of underlying conditions such as glaucoma, ischemia, multiple sclerosis, hereditary disorders, or trauma. Its complex etiology and irreversible nature make it difficult to treat, pushing research efforts toward neuroprotection, regenerative therapies, and early…
More Releases for Pars
Pars Planitis Market Dynamics Indicate Upward Trajectory Through 2032, Reports D …
DelveInsight's "Pars Planitis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Pars Planitis, historical and forecasted epidemiology as well as the Pars Planitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pars Planitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pars Planitis Market Forecast
https://www.delveinsight.com/sample-request/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Global Pars Planitis Treatment Market Projected to Grow at 7.7% CAGR, Reaching $ …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Pars Planitis Treatment Industry Market Size Be by 2025?
In the past, the market size for the treatment of pars planitis has seen substantial expansion. The market value is poised to increase from $632.88 billion in 2024 to $683.54 billion in 2025, with a compound annual…
Global Pars Planitis Treatment Market Achieves Significant Growth in 2022 and Fo …
In 2022, the global Pars Planitis treatment market attained a valuation of US$ YY billion, with projections to reach US$ YY billion by 2030. The market is set to experience a robust Compound Annual Growth Rate (CAGR) of YY% during the forecast period spanning from 2023 to 2030.
The global Pars Planitis treatment market has undergone notable growth and transformations, driven by various factors shaping its dynamics. Pars Planitis, a persistent…
Cellular Glass Market Insight 2020-2027 | Benarx, Jahan Ayegh Pars Co., Langfang …
Allied Market Research recently published a report titled, "Cellular Glass Market by Product Type (Block & Shell and Foam Glass Gravel), Type (Open Glass and Closed Glass), and Application (Construction, Industrial, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027". According to the report, the recent technological advancements and launch of new products have a significant influence on the growth. The report includes a detailed analysis of the market trends,…
Pars Planitis Market Growth Elements, Recent Developments, and Key Players Strat …
Pars Planitis Market 2023 by Technology, Manufacturers, Regions, Type, and Application, Forecast guide to light the excellent analysis on the market synopsis. The report offers a primary focus on important factors in the global Pars Planitis industry. The report includes perceptive information about gross revenue, cost, value, capacity, pricing, and profit margins concerning historical analysis and forecast estimation for the 2023 to 2031 time period. It presents a close overview…
Global Styrene Market 2017 - Shell, Total, SINOPEC, BASF, Versalis, Pars
Global Styrene market Report offers decisive insights into the overall Styrene industry along with the market dimensions and evaluation for the duration 2017 to 2022. The forenamed research study covers extensive analysis of various Styrene industry segments based on the type of applications, type of product Components and services, and different geographical regions.
Styrene, also known as ethenylbenzene, vinylbenzene, and phenylethene, is an organic compound with the chemical formula C6H5CH=CH2.…
